TRAJECTORY is an interdisciplinary and intersectoral research and training consortium project funded by the French National Research Agency (ANR) and consisting of 14 beneficiaries and 11 non-academic partners brought together under the 2023 Marie Skłodowska-Curie Actions (MSCA) Doctoral Networks (DN) call. In case of funding, the common goal of the different TRAJECTORY stakeholders will be to offer a training programme in different sectors across Europe in order to educate highly qualified PhD students and to enhance their long-term employability in the field of tumour heterogeneity.
Learn more about TRAJECTORY
